The APPSAA mouse model (containing the humanized APP with three familial Alzheimer’s disease mutations) and the APPWT control (containing wildtype humanized APP) are the first commercially available APP KI mice within the United States. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.